Summary-Morphine and related opioid compounds are known to possess proconvulsant activity based upon both electroencephalographic and behavioral criteria. The present authors previously suggested that opiate-related seizures were behaviorally inhibitory, and this was further investigated in the present study. The effects of pretreatment with three pharmacologically distinct compounds (sodium valproic acid, trimethadione, taurine) upon normal behavioral activation to systemic morphine were examined in the mouse. Morphine consistently increased activity levels in comparison with vehicle. Each of the three experimental compounds itself was behaviorally inhibitory; nonetheless both sodium valproate and trimethadione facilitated behavioral responses to morphine. The effects of the same drugs upon activation produced by central administration of a long-lasting enkephalin analog (o-ala'-leu-enkephalinamide) were investigated, with similar results. These findings confirm a behavioral interaction between opiate and anticonvulsant drugs, although it may be selective for certain classes of anticonvulsant compounds.
between endogenous and exogenous opiates and anticonvulsant drugs, with anticonvulsants facilitating behavioral activation to opiates. It may be inferred that some property of opiates, possibly related to seizures, normally inhibits at least certain classes of behavior and this additionally supported electroencephalographically (e.g. Urea, Frenk, Liebeskind and Taylor, 1977; Tortella, Moreton and Khazan, 1978) . To date, only a limited number of ~ticonvulsants have been evafuated for their effects upon opiates, either behaviorally or electroencephalographicaiiy. Given the range of anticonv&ant drugs with both related and distinctive modes of action, the generality of effects across drug categories might merit additional examination and comment.
To investigate the presence and generality of previously reported behavioral interadtions, opiate and opioid running after pretreatment with a variety of anticonvulsant drugs was examined. In particular, the pharmacolo~cally distinct ~ticonvuisants, sodium valproate, trimethadione and taurine were examined for their effects upon behavioral activation induced either by systemic morphine or by central injection of a long-lasting enkephalin analog (D-ala'-leu-enkephalinamide).
Examination of enkephalin analogs may shed further tight upon the reported behavioral effects. The use of analogs allows examination of the generality of the reported interaction across opioid classes and may enable further specification of the mechanisms underlying their effects. For example, one possible explanation of results based upon systemic opiate administration is essentially pharmacokinetic in nature. The behaviorally effective anticonvulsants may have affected morphine disposition in a manner permitting altered tissue levels, including brain levels, thereby producing a changed behavioral effect. Such effects are ruled out in the present design since enkephalin injections were central, standardized and directed to a single tissue, thereby eliminating effects due to altered disposition across tissues.
METHODS

Subjects
Adult male Swiss-Webster mice, 30-3.5 g each, were group housed with food (Teklad 4.0% fat rodent diet S-0836) and tap water continuously available and a 12 hr/lZ hr light-dark cycle (lights on = 0700-1900). Cell sample sizes for the first experiment (based upon systemic morphine) were PI = 36, run as 9 cells of grouped mice (n = 4,lcagef per data point. In the experiment involving central enkephalin injections, each data point was based upon 5 mice, run individually. The use of grouped mice in assessing morphine effects upon activity is a standard procedure in this and other laboratories (e.g. Katz and Schmaltz, 1979 (1978) and Katz and Schmaltz (1979) .
Behavioral procedure
Grouped
or individual for enkephalin injections, the mice were initially habituated to apparatus placement and injection (0.9% sodium chloride, lOml/kg) procedures in 8 sessions each of 4-6 hr duration. On the test day, subjects were placed on the apparatus beginning at 080@0900 hr. Five hours were allowed for further and final habituation before testing, at which point subjects were briefly removed and injected with vehicle or anticonvulsant.
Thirty minutes later mice were injected with vehicle or opiate. Experimental recording continued for ten consecutive 10 min blocks. 9.432; 9.655. P = 0.1). reliable effects of drug (i.e. morphine) by time (respective F's = 4.7. 4.2, 3.8. d.f. =,9,432: 9.432; 9,655, P < 0.01) and three way interactions [F's = 7.9, 6.2, 1.0; d.f. = 18.432; 18,432; 24,655; P < 0.01 except taurine (NS) were found.
Effects of anticonvulsants by time were not significant beyond chance (F's < 1) except for taurine (F = 2.1: d.f. = 24,655; P < 0.001).
Central injections of the enkephalin analog produced a graded behavioral response and both trimethadione and valproic acid shifted the enkephalin analog behavioral response curve to the left (Fig. 4) . Taurine lacked this effect (Fig. 4) . The behavioral findings are consistent both with the previous findings and the results of the last experiment. The main effect for the enkephalin analog was statistically reliable beyond chance (F = 13.1; d.f. = 3,64; P < 0.001) and both valproic acid and trimethadione significantly increased the level of opioid activity, shifting the doseresponse curve (F's = 9.9,8.9 respectively; d.f. = 9.64; P < 0.001; for taurine, F = 1.8, P -0.3). Time was not a main factor (all F's < 1.2; d.f. = 8,597), although time did interact with enkephalin (F = 18.0: d.f. = 24,597) and, in addition, a three-way interaction was present (F = 3.1: d.f. = 72,597).
DISCUSSION
The present findings extend previous findings by Katz and Schmaltz (1979) to two novel but clinically used anticonvulsant drugs (trimethadione and sodium valproate). The effect was not present for taurine, at least within the present dose range: this may be explained by a number of unique postulated modes of action of the latter. Unlike other anticonvulsants, taurine is not an effective treatment for kindled seizures which may represent an experimental analog of epilepsy (Wada, Osawa. Wake and Corcoran. 1975) . Furthermore, in yet other preclinical models, taurine was shown to have a proconvulsant effect (Frigyesi and Lombardini. 1979) . Although these findings do not rule out positive clinical findings, especially given procedural variations such as chronic administration. they do offer potential explanations of the discrepant actions of taurine in the present model.
The findings with the analog confirm and extend previous studies on opiate-anticonvulsant interactions. As with morphine, an effect was seen for two compounds, valproic acid and trimethadione, but not for a third, taurine. The reasons for an absence of effect with the latter compound have already been suggested. The present findings suggest that the effects of anticonvulsants are not upon drug disposition, nor restricted to a single opiate.
The findings, taken as a whole, suggest that actions of opiates which are altered by anticonvulsant treatment are behaviorally significant. The facilitation effects are not found in certain classes of therapeutically effective compounds however, at least in the present testing circumstances.
Thus, it may be concluded that anticonvulant facilitation of opiate effects is general, but apparently not universal.
